Ly Vu
- Cancer Research top 2%
- Cancer-related molecular mechanisms research 5
- Molecular Biology top 5%
- RNA modifications and cancer 13
- Cancer-related gene regulation 11
- RNA Research and Splicing 10
- Epigenetics and DNA Methylation 4
- Protein Degradation and Inhibitors 4
- Sensory Systems top 5%
- Hearing, Cochlea, Tinnitus, Genetics 4
- Hematology top 10%
- Acute Myeloid Leukemia Research 5
- Co-authors
- Michael G. KharasYuanming ChengDiu NguyenSamie R. JaffreyBrian F. PickeringAri MelnickGerard MinuesaJessica Schulman
- Partner nations
- United StatesCanadaSwitzerland
In The Last Decade
Ly Vu
38 papers receiving 1.6k citations
Hit Papers
Peers
Comparison fields: 5 of 84
- Cancer Research 666
- Molecular Biology 1.5k
- Sensory Systems 80
- Hematology 110
- Oncology 143
Countries citing papers authored by Ly Vu
This map shows the geographic impact of Ly Vu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ly Vu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ly Vu more than expected).
Fields of papers citing papers by Ly Vu
This network shows the impact of papers produced by Ly Vu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ly Vu. The network helps show where Ly Vu may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Ly Vu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 2 | |
| 2 | 2024 | 8 | |
| 3 | 2024 | 4 | |
| 4 | 2024 | 11 | |
| 5 | 2023 | 5 | |
| 6 | 2023 | 17 | |
| 7 | 2022 | 1 | |
| 8 | Fluoroscopy Discography Assessment, Protocols, and Interpretation | 2021 | 1 |
| 9 | 2020 | 36 | |
| 10 | 2019 | 126 | |
| 11 | 2018 | 124 | |
| 12 | The N6-methyladenosine (m6A)-forming enzyme METTL3 controls myeloid differentiation of normal hematopoietic and leukemia cellsbreakdown → | 2017 | 932 |
| 13 | 2015 | 5 | |
| 14 | PRMT4 blocks myeloid differentiation by assembling a methyl-RUNX1-dependent repressor complex | 2013 | 1 |
| 15 | 2013 | 73 | |
| 16 | 2012 | 49 | |
| 17 | 2012 | 13 | |
| 18 | 2011 | 27 | |
| 19 | 2009 | 28 | |
| 20 | Effect of exogenous glutathione supplementation on motility, viability, and DNA integrity of frozen-thawed boar semen | 2008 | 22 |
About Ly Vu
Ly Vu is a scholar working on Sensory Systems, Otorhinolaryngology, Hematology, Molecular Biology and Cancer Research, having authored 38 papers that have together received 1.7k indexed citations. Recurring topics across this work include RNA modifications and cancer (13 papers), Cancer-related gene regulation (11 papers), RNA Research and Splicing (10 papers), Acute Myeloid Leukemia Research (5 papers), Cancer-related molecular mechanisms research (5 papers), Hearing, Cochlea, Tinnitus, Genetics (4 papers), Epigenetics and DNA Methylation (4 papers) and Protein Degradation and Inhibitors (4 papers). The work is most often cited by research in Cancer Research (666 citations), Molecular Biology (1.5k citations), Sensory Systems (80 citations), Hematology (110 citations) and Oncology (143 citations). Ly Vu has collaborated with scholars based in United States, Canada and Switzerland. Frequent co-authors include Michael G. Kharas, Yuanming Cheng, Diu Nguyen, Samie R. Jaffrey, Brian F. Pickering, Ari Melnick, Gerard Minuesa, Jessica Schulman, Minal Patel and Christopher E. Mason. Their work appears in journals such as Blood, Cell Reports, International Journal of Hematology, Cancer Discovery and Nature Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.